Kargi, A. Et Al. 2012. IL8 and STRAIL levels following anti-vascular endothelial growth factor monoclonal antibody treatment in patients with metastatic colon cancer. 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (Geneva, Switzerland), 553.

Kargi, A., Yalcin, A., Erin, N., Savas, B., Polat, H., & Gorczynski, R., (2012). IL8 and STRAIL levels following anti-vascular endothelial growth factor monoclonal antibody treatment in patients with metastatic colon cancer . 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.553). Geneva, Switzerland

Kargi, A. Et Al. "IL8 and STRAIL levels following anti-vascular endothelial growth factor monoclonal antibody treatment in patients with metastatic colon cancer," 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Geneva, Switzerland, 2012

Kargi, A. Et Al. "IL8 and STRAIL levels following anti-vascular endothelial growth factor monoclonal antibody treatment in patients with metastatic colon cancer." 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Geneva, Switzerland, pp.553, 2012

Kargi, A. Et Al. (2012) . "IL8 and STRAIL levels following anti-vascular endothelial growth factor monoclonal antibody treatment in patients with metastatic colon cancer." 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Geneva, Switzerland, p.553.

@conferencepaper{conferencepaper, author={A. Kargi Et Al. }, title={IL8 and STRAIL levels following anti-vascular endothelial growth factor monoclonal antibody treatment in patients with metastatic colon cancer}, congress name={31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={Geneva}, country={Switzerland}, year={2012}, pages={553} }